Sfoglia per Autore
NMDA Receptor and Its Emerging Role in Cancer
2023-01-01 Gallo, Simona; Vitacolonna, Annapia; Crepaldi, Tiziana
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor
2022-01-01 Altintas, Dogus Murat; Gallo, Simona; Basilico, Cristina; Cerqua, Marina; Bocedi, Alessio; Vitacolonna, Annapia; Botti, Orsola; Casanova, Elena; Rancati, Ilaria; Milanese, Chiara; Notari, Sara; Gambardella, Giorgia; Ricci, Giorgio; Mastroberardino, Pier Giorgio; Boccaccio, Carla; Crepaldi, Tiziana; Comoglio, Paolo Maria
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
2022-01-01 Gallo, Simona; Vitacolonna, Annapia; Comoglio, Paolo; Crepaldi, Tiziana
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing
2021-01-01 Galluzzo A.; Gallo S.; Pardini B.; Birolo G.; Fariselli P.; Boretto P.; Vitacolonna A.; Peraldo-Neia C.; Spilinga M.; Volpe A.; Celentani D.; Pidello S.; Bonzano A.; Matullo G.; Giustetto C.; Bergerone S.; Crepaldi T.
HGF and MET: From Brain Development to Neurological Disorders
2021-01-01 Desole, Claudia; Gallo, Simona; Vitacolonna, Annapia; Montarolo, Francesca; Bertolotto, Antonio; Vivien, Denis; Comoglio, Paolo; Crepaldi, Tiziana
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
2021-01-01 Desole C.; Gallo S.; Vitacolonna A.; Vigna E.; Basilico C.; Montarolo F.; Zuppini F.; Casanova E.; Miggiano R.; Ferraris D.M.; Bertolotto A.; Comoglio P.M.; Crepaldi T.
Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody
2020-01-01 Modica C.; Gallo S.; Chiriaco C.; Spilinga M.; Comoglio P.M.; Crepaldi T.; Basilico C.; Vigna E.
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro
2020-01-01 Gallo S.; Spilinga M.; Albano R.; Ferrauto G.; Di Gregorio E.; Casanova E.; Balmativola D.; Bonzano A.; Boccaccio C.; Sapino A.; Comoglio P.M.; Crepaldi T.
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3
2020-01-01 Gallo S.; Spilinga M.; Casanova E.; Bonzano A.; Boccaccio C.; Comoglio P.M.; Crepaldi T.
ERK: A key player in the pathophysiology of cardiac hypertrophy
2019-01-01 Gallo S.; Vitacolonna A.; Bonzano A.; Comoglio P.; Crepaldi T.
Hepatocyte Growth Factor Receptor
2017-01-01 SIMONA GALLO, PAOLO MARIA COMOGLIO, TIZIANA CREPALDI
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart
2016-01-01 Sala, Valentina; Gatti, Stefano; Gallo, Simona; Medico, Enzo; Cantarella, Daniela; Cimino, James; Ponzetto, Antonio; Crepaldi, Tiziana
HGF/Met tyrosine kinase receptor in heart physiology and pathophysiology
2016-01-01 Crepaldi, Tiziana; Gallo, Simona; Gatti, Stefano; Sala, Valentina; Bonzano, Alessandro; Paolo Maria Comoglio,
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
2016-01-01 Sala, Valentina; Gallo, Simona; Gatti, Stefano; Medico, Enzo; Vigna, Elisa; Cantarella, Daniela; Fontani, Lara; Natale, Massimo; Cimino, James; Morello, Mara; Comoglio, Paolo Maria; Ponzetto, Antonio; Crepaldi, Tiziana
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy
2015-01-01 Sala, Valentina; Gatti, Stefano; Gallo, Simona; Cantarella, Daniella; Medico, Enzo; Ponzetto, Antonio; Crepaldi, Tiziana
Met activation for cardioprotection against anthracyclines cardiotoxicity
2015-01-01 Gallo S; Gatti S; Bonzano A; Albano R; Sala V; Comoglio P; Crepaldi T
Cellular and molecular mechanisms of HGF/Met in the cardiovascular system
2015-01-01 Gallo, S.; Sala, V.; Gatti, S.; Crepaldi, T.
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor.
2015-01-01 Sala, V.; Gallo, S.; Gatti, S.; Medico, E.; Vigna, E.; Cantarella, D.; Fontani, L.; Natale, M.; Morello, M.; Ponzetto, A.; Crepaldi, T.
Met activation for cardioprotection against anthracycline cardiotoxicity.
2015-01-01 Gallo, S.; Gatti, S.; Bonzano, A.; Albano, R.; Sala, V.; Comoglio, P.M.; Crepaldi, T.
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes
2015-01-01 Valentina Sala;Simona Gallo;Stefano Gatti;Elisa Vigna;Antonio Ponzetto;Tiziana Crepaldi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| NMDA Receptor and Its Emerging Role in Cancer | 2023 | Gallo, Simona; Vitacolonna, Annapia; Crepaldi, Tiziana | |
| The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor | 2022 | Altintas, Dogus Murat; Gallo, Simona; Basilico, Cristina; Cerqua, Marina; Bocedi, Alessio; Vitacolonna, Annapia; Botti, Orsola; Casanova, Elena; Rancati, Ilaria; Milanese, Chiara; Notari, Sara; Gambardella, Giorgia; Ricci, Giorgio; Mastroberardino, Pier Giorgio; Boccaccio, Carla; Crepaldi, Tiziana; Comoglio, Paolo Maria | |
| MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor | 2022 | Gallo, Simona; Vitacolonna, Annapia; Comoglio, Paolo; Crepaldi, Tiziana | |
| Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing | 2021 | Galluzzo A.; Gallo S.; Pardini B.; Birolo G.; Fariselli P.; Boretto P.; Vitacolonna A.; Peraldo-Neia C.; Spilinga M.; Volpe A.; Celentani D.; Pidello S.; Bonzano A.; Matullo G.; Giustetto C.; Bergerone S.; Crepaldi T. | |
| HGF and MET: From Brain Development to Neurological Disorders | 2021 | Desole, Claudia; Gallo, Simona; Vitacolonna, Annapia; Montarolo, Francesca; Bertolotto, Antonio; Vivien, Denis; Comoglio, Paolo; Crepaldi, Tiziana | |
| Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor | 2021 | Desole C.; Gallo S.; Vitacolonna A.; Vigna E.; Basilico C.; Montarolo F.; Zuppini F.; Casanova E.; Miggiano R.; Ferraris D.M.; Bertolotto A.; Comoglio P.M.; Crepaldi T. | |
| Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody | 2020 | Modica C.; Gallo S.; Chiriaco C.; Spilinga M.; Comoglio P.M.; Crepaldi T.; Basilico C.; Vigna E. | |
| Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro | 2020 | Gallo S.; Spilinga M.; Albano R.; Ferrauto G.; Di Gregorio E.; Casanova E.; Balmativola D.; Bonzano A.; Boccaccio C.; Sapino A.; Comoglio P.M.; Crepaldi T. | |
| The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 | 2020 | Gallo S.; Spilinga M.; Casanova E.; Bonzano A.; Boccaccio C.; Comoglio P.M.; Crepaldi T. | |
| ERK: A key player in the pathophysiology of cardiac hypertrophy | 2019 | Gallo S.; Vitacolonna A.; Bonzano A.; Comoglio P.; Crepaldi T. | |
| Hepatocyte Growth Factor Receptor | 2017 | SIMONA GALLO, PAOLO MARIA COMOGLIO, TIZIANA CREPALDI | |
| A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart | 2016 | Sala, Valentina; Gatti, Stefano; Gallo, Simona; Medico, Enzo; Cantarella, Daniela; Cimino, James; Ponzetto, Antonio; Crepaldi, Tiziana | |
| HGF/Met tyrosine kinase receptor in heart physiology and pathophysiology | 2016 | Crepaldi, Tiziana; Gallo, Simona; Gatti, Stefano; Sala, Valentina; Bonzano, Alessandro; Paolo Maria Comoglio, | |
| Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib | 2016 | Sala, Valentina; Gallo, Simona; Gatti, Stefano; Medico, Enzo; Vigna, Elisa; Cantarella, Daniela; Fontani, Lara; Natale, Massimo; Cimino, James; Morello, Mara; Comoglio, Paolo Maria; Ponzetto, Antonio; Crepaldi, Tiziana | |
| Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy | 2015 | Sala, Valentina; Gatti, Stefano; Gallo, Simona; Cantarella, Daniella; Medico, Enzo; Ponzetto, Antonio; Crepaldi, Tiziana | |
| Met activation for cardioprotection against anthracyclines cardiotoxicity | 2015 | Gallo S; Gatti S; Bonzano A; Albano R; Sala V; Comoglio P; Crepaldi T | |
| Cellular and molecular mechanisms of HGF/Met in the cardiovascular system | 2015 | Gallo, S.; Sala, V.; Gatti, S.; Crepaldi, T. | |
| Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. | 2015 | Sala, V.; Gallo, S.; Gatti, S.; Medico, E.; Vigna, E.; Cantarella, D.; Fontani, L.; Natale, M.; Morello, M.; Ponzetto, A.; Crepaldi, T. | |
| Met activation for cardioprotection against anthracycline cardiotoxicity. | 2015 | Gallo, S.; Gatti, S.; Bonzano, A.; Albano, R.; Sala, V.; Comoglio, P.M.; Crepaldi, T. | |
| Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes | 2015 | Valentina Sala;Simona Gallo;Stefano Gatti;Elisa Vigna;Antonio Ponzetto;Tiziana Crepaldi |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile